Attitudes toward clinical trials among patients with sickle cell disease

Abstract

Background

A substantial number of planned clinical trials for sickle cell disease (SCD) have terminated early due to insufficient patient enrollment.

Purpose

To describe attitudes toward clinical trials among a sample of adults with SCD and identify patient-level factors associated with these attitudes.

Methods

Our data came from a sample (N = 291) of primarily adults with SCD participating in the Improving Patient Outcomes with Respect and Trust (IMPORT) study, which is a federally funded observational study of SCD patient experiences in seeking healthcare. Attitudes toward clinical trials were assessed using items from the Perceptions of Participation in Clinical Research instrument. Patient factors examined as potential correlates of clinical trial attitudes were demographics, disease severity, engagement in self-care, trust, healthcare experience ratings, and prior history of participation in clinical trials. Multiple regression analyses were used to identify patient-level correlates of clinical trial attitudes.

Results

Our sample of SCD patients expressed overwhelmingly favorable attitudes about clinical trials, with 77%–92% of our sample expressing agreement with a series of positive statements about clinical trials in general. Demographics, engagement in self-care, healthcare experience ratings, and prior trial participation each explained significant portions of the variability in clinical trial attitudes.

Limitations

The generalizability of our results to the entire SCD population may be of concern as the study participants were all receiving care at comprehensive sickle cell centers and already participating in clinical research.

Conclusion

Our results suggest that, in principle, adults with SCD enrolled in an observational study express very positive general attitudes about clinical trial participation and that specific factors attached to particular clinical trial opportunities may play a greater role in a SCD patient’s decision to participate than a general unwillingness to participate.

Get full access to this article

View all access options for this article.

References

Hoots

Shurin

. Future directions of sickle cell disease research: The NIH perspective. Pediatr Blood Cancer 2012; 59: 353–57.

Kaye

, Committee on Genetics, Accurso

La Franchi

Lane

. Newborn screening fact sheets. Pediatrics 2006; 118: e934–63.

Weatherall

. The inherited disorders of haemoglobin: An increasingly neglected global health burden. Indian J Med Res 2011; 134: 493–97.

Scott

. Health care priority and sickle cell anemia. JAMA 1970; 214: 731–34.

Smith

Oyeku

Homer

. Sickle cell disease: A question of equity and quality. Pediatrics 2006; 117: 1763–70.

Peters-Lawrence

Bell

Hsu

. Clinical trial implementation and recruitment: Lessons learned from the early closure of a randomized clinical trial. Contemp Clin Trials 2012; 33: 291–97.

US National Institutes of Health. ClinicalTrials.gov. Available at: http://clinicaltrials.gov (accessed 7 July 2013).

Barakat

Patterson

Mondestin

. Initial development of a questionnaire evaluating perceived benefits and barriers to pediatric clinical trials participation. Contemp Clin Trials 2013; 34: 218–26.

Liem

Cole

Pelligra

. Parental attitudes toward research participation in pediatric sickle cell disease. Pediatr Blood Cancer 2010; 55: 129–33.

10.

Jones

Broome

. Focus groups with African American adolescents: Enhancing recruitment and retention in intervention studies. J Pediatr Nurs 2001; 16: 88–96.

11.

Wynn

Miller

Faughnan

. Recruitment of infants with sickle cell anemia to a Phase III trial: Data from the BABY HUG study. Contemp Clin Trials 2010; 31: 558–63.

12.

Nield-Anderson

Dixon

Lee

. Random assignment and patient choice in a study of alternative pain relief for sickle cell disease. West J Nurs Res 1999; 21: 266–74.

13.

Omondi

Ferguson

Majhail

. Barriers to hematopoietic cell transplantation clinical trial participation of African American and Black youth with sickle cell disease and their parents. J Pediatr Hematol Oncol 2013; 35: 289–98.

14.

Shavers-Hornaday

Lynch

Burmeister

. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health 1997; 2: 31–45.

15.

Schmotzer

. Barriers and facilitators to participation of minorities in clinical trials. Ethn Dis 2012; 22: 226–30.

16.

Rivers

August

Sehovic

. A systematic review of the factors influencing African Americans’ participation in cancer clinical trials. Contemp Clin Trials 2013; 35: 13–32.

17.

Rivera-Goba

Dominguez

Stoll

. Exploring decision-making of HIV-infected Hispanics and African Americans participating in clinical trials. J Assoc Nurses AIDS Care 2011; 22: 295–306.

18.

Corbie-Smith

Thomas

Williams

. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 1999; 14: 537–46.

19.

Kennedy

Burnett

. Clinical research trials: A comparison of African Americans who have and have not participated. J Cult Divers 2002; 9: 95–101.

20.

Kennedy

Burnett

. Clinical research trials: Factors that influence and hinder participation. J Cult Divers 2007; 14: 141–47.

21.

Edwards

Telfair

Cecil

. Reliability and validity of a self-efficacy instrument specific to sickle cell disease. Behav Res Ther 2000; 38: 951–63.

22.

Lenoci

Telfair

Cecil

. Self-care in adults with sickle cell disease. West J Nurs Res 2002; 24: 228–45.

23.

Hays

Shaul

Williams

. Psychometric properties of the CAHPS 1.0 survey measures. Consumer Assessment of Health Plans Study. Med Care 1999; 37: MS22–31.

24.

Stewart

Napoles-Springer

Perez-Stable

. Interpersonal processes of care in diverse populations. Milbank Q 1999; 77: 305–39.

25.

Stewart

Napoles-Springer

Gregorich

. Interpersonal processes of care survey: Patient-reported measures for diverse groups. Health Serv Res 2007; 42: 1235–56.

26.

Dugan

Trachtenberg

Hall

. Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res 2005; 5: 64.

27.

Rose

Peters

Shea

. Development and testing of the health care system distrust scale. J Gen Intern Med 2004; 19: 57–63.

28.

Cohen

. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences (2nd edn). Lawrence Erlbaum Associates, Inc., Hillsdale, NJ, 1983.

29.

StataCorp. Stata statistical software (Release 12). College Station, TX: StataCorp, 2011.

30.

Haywood

Jr Lanzkron

Ratanawongsa

. The association of provider communication with trust among adults with sickle cell disease. J Gen Intern Med 2010; 25: 543–48.

31.

Haywood

Jr Lanzkron

Ratanawongsa

. Hospital self-discharge among adults with sickle-cell disease (SCD): Associations with trust and interpersonal experiences with care. J Hosp Med 2010; 5: 289–94.

32.

Elander

Beach

Haywood

Jr.

Respect, trust, and the management of sickle cell disease pain in hospital: Comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice. Ethn Health 2011; 16: 405–21.